Establishment Labs Holdings Inc. (ESTA)
NASDAQ: ESTA · Real-Time Price · USD
39.50
-1.31 (-3.20%)
Apr 1, 2025, 10:19 AM EDT - Market open

Company Description

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries.

The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders.

The company sells its products to physicians, hospitals, and clinics through distributors and its direct sales force in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America.

Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

Establishment Labs Holdings Inc.
Establishment Labs Holdings logo
Country Costa Rica
Founded 2004
IPO Date Jul 19, 2018
Industry Medical Devices
Sector Healthcare
Employees 1,018
CEO Filippo Caldini

Contact Details

Address:
Building B23 and B25, Coyol Free Zone
Alajuela
Costa Rica
Phone 506 2434 2400
Website establishmentlabs.com

Stock Details

Ticker Symbol ESTA
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001688757
CUSIP Number G31249108
ISIN Number VGG312491084
Employer ID 98-1436377
SIC Code 3842

Key Executives

Name Position
Filippo Caldini Interim Chief Executive Officer and President
Juan Jose Chacon Quiros Founder and Executive Director
Rajbir Singh Denhoy Chief Financial Officer
S. Ross Mansbach General Counsel, Chief Compliance Officer and Chief Human Resources Officer
Roberto de Mezerville Chief Technology Officer
Salvador Santos Dada Head of Special Projects
Rosalyn Cole d'Incelli SVice President of Global Clinical, Medical and US Regulatory Affairs
Ivan Bilic Senior Vice President of Commercial Operations - OUS
Jeff Ehrhardt Senior Vice President and GM of North America
Neeta Toprani Corporate Secretary

Latest SEC Filings

Date Type Title
Feb 28, 2025 S-8 Securities to be offered to employees in employee benefit plans
Feb 28, 2025 10-K Annual Report
Feb 26, 2025 8-K Current Report
Feb 14, 2025 SCHEDULE 13G/A Filing
Feb 14, 2025 SCHEDULE 13G/A Filing
Feb 13, 2025 SCHEDULE 13G/A Filing
Feb 11, 2025 SCHEDULE 13G/A Filing
Jan 16, 2025 8-K Current Report
Jan 13, 2025 8-K Current Report
Nov 14, 2024 SCHEDULE 13G/A Filing